SFN induces overexpression of novel tumor suppressors miR-135b-5p and RASAL2 in highly aggressive pancreatic cancer cell lines and effectively inhibits tumor cell growth in vitro and in vivo (Yin et al. 2019). The gene discussed is RASAL2; the disease is neoplasm.